NEW: Premarket Now Starts at 4AM!

We’re excited to announce the extension of premarket and aftermarket hours! Our members now have access to quotes daily from 4:00 AM to 8:00 PM ET — offering greater flexibility and deeper insights into market trends beyond regular trading hours.

Upgrade to FINVIZ*Elite to access premarket quotes »

Last Close
May 09 12:20PM ET
3.98
Dollar change
+0.05
Percentage change
1.27
%
Index- P/E- EPS (ttm)-75.32 Insider Own43.50% Shs Outstand42.32M Perf Week1.53%
Market Cap173.84M Forward P/E- EPS next Y-0.44 Insider Trans0.00% Shs Float24.68M Perf Month1.02%
Income-16.70M PEG- EPS next Q-0.12 Inst Own5.11% Short Float7.77% Perf Quarter-6.79%
Sales0.00M P/S- EPS this Y95.77% Inst Trans263.81% Short Ratio9.19 Perf Half Y-20.08%
Book/sh0.34 P/B11.77 EPS next Y7.75% ROA-129.96% Short Interest1.92M Perf Year-26.02%
Cash/sh0.43 P/C9.32 EPS next 5Y75.00% ROE-203.07% 52W Range1.80 - 14.60 Perf YTD-2.69%
Dividend Est.- P/FCF- EPS past 5Y76.02% ROI-114.13% 52W High-72.73% Beta0.29
Dividend TTM- Quick Ratio3.68 Sales past 5Y0.00% Gross Margin- 52W Low121.11% ATR (14)0.33
Dividend Ex-Date- Current Ratio3.68 EPS Y/Y TTM64.00% Oper. Margin- RSI (14)54.71 Volatility8.26% 9.02%
Employees19 Debt/Eq0.01 Sales Y/Y TTM- Profit Margin- Recom1.00 Target Price12.08
Option/ShortNo / Yes LT Debt/Eq0.00 EPS Q/Q98.29% Payout- Rel Volume0.35 Prev Close3.93
Sales Surprise- EPS Surprise- Sales Q/Q- EarningsApr 01 BMO Avg Volume208.63K Price3.98
SMA20-1.06% SMA5017.31% SMA200-19.93% Trades Volume34,192 Change1.27%
Date Action Analyst Rating Change Price Target Change
Mar-03-25Initiated H.C. Wainwright Buy $13
Dec-19-24Initiated Rodman & Renshaw Buy $11
Nov-05-24Initiated Maxim Group Buy $15
May-05-25 08:00AM
Apr-28-25 08:00AM
Apr-18-25 03:26PM
Apr-08-25 08:00AM
Apr-07-25 08:24AM
08:00AM Loading…
Apr-01-25 08:00AM
Mar-11-25 08:05AM
Mar-10-25 09:00AM
Feb-19-25 09:00AM
Dec-12-24 08:45AM
Nov-25-24 08:35AM
Oct-23-24 08:30AM
Oct-22-24 09:00AM
Oct-17-24 04:35PM
Oct-16-24 12:54PM
11:58AM Loading…
11:58AM
Oct-15-24 04:15PM
Oct-14-24 08:30AM
Oct-09-24 07:28AM
Oct-08-24 07:00AM
Sep-20-24 09:25AM
Sep-18-24 08:30AM
Sep-11-24 08:30AM
Sep-09-24 08:30AM
Aug-19-24 09:00AM
Jul-08-24 06:30AM
Jul-01-24 08:35AM
Jun-21-24 07:52AM
Jun-03-24 08:35AM
May-30-24 07:47AM
07:36AM Loading…
May-20-24 07:36AM
May-14-24 10:53PM
04:45PM
Apr-04-24 10:38AM
Apr-03-24 09:46AM
07:00AM
Mar-27-24 09:00AM
Feb-14-24 04:07PM
Feb-12-24 09:00AM
Dec-07-23 09:00AM
Dec-05-23 09:00AM
Nov-13-23 04:10PM
Oct-31-23 08:00AM
Oct-11-23 08:00AM
Oct-02-23 08:00AM
Sep-25-23 07:30AM
Sep-21-23 09:35AM
Sep-18-23 04:25PM
Sep-05-23 08:00AM
Aug-17-23 05:00PM
Aug-09-23 08:16AM
Aug-08-23 07:00AM
Jul-19-23 08:00AM
Jun-30-23 11:07AM
Jun-28-23 04:15PM
Jun-16-23 08:00AM
May-19-23 08:30AM
May-11-23 08:15AM
May-09-23 07:15AM
May-08-23 08:30AM
May-01-23 08:30AM
Apr-14-23 12:00PM
Mar-15-23 08:00AM
Mar-10-23 08:30AM
Feb-14-23 05:00PM
Jan-30-23 08:00AM
Jan-09-23 08:30AM
Dec-15-22 08:00AM
Dec-02-22 09:47AM
Dec-01-22 08:00AM
Nov-30-22 08:00AM
Nov-28-22 08:00AM
Nov-18-22 08:00AM
Nov-11-22 08:00AM
Nov-09-22 05:20PM
Oct-19-22 08:15AM
Sep-27-22 08:15AM
Sep-08-22 07:00AM
Aug-09-22 09:00AM
Aug-03-22 08:30AM
Jun-21-22 08:00AM
Jun-15-22 09:00AM
Jun-10-22 09:00AM
Jun-03-22 09:00AM
May-27-22 09:30AM
May-17-22 07:00AM
May-13-22 08:00AM
Apr-27-22 09:00AM
Apr-26-22 07:30AM
Apr-14-22 04:05PM
Apr-12-22 11:47AM
08:30AM
Apr-11-22 02:30PM
Mar-22-22 08:00AM
Mar-15-22 07:00AM
Feb-14-22 06:10AM
Feb-11-22 08:15AM
Feb-04-22 07:00AM
Feb-03-22 07:00AM
Jan-25-22 07:45AM
TuHURA Biosciences, Inc. is a clinical-stage immuno-oncology company, which engages in the development of novel technologies to overcome resistance to cancer immunotherapy. The firm's lead product candidate, IFx2.0, is an innate immune agonist designed to overcome primary resistance to checkpoint inhibitors. The company was founded on May 4, 2023 and is headquartered in Tampa, FL.